Booster shots approved for adolescents aged 12 to 17

Following approval by the Government Executive Committee, and based on the latest international data and developments, the National Medical Taskforce for Combatting the Coronavirus (COVID-19), has announced that the booster shot has been made available by choice for adolescents aged 12 to 17 years, starting Wednesday, 12 January 2022.
 
Adolescents in this age group who have received two doses of the Sinopharm vaccine will be offered the Sinopharm or Pfizer-BioNTech booster shots, approved for use from six months after the second dose.  However, adolescents who have received both doses of the Pfizer-BioNTech vaccine will be offered the Pfizer-BioNTech booster shot only, also six months after the second dose.
 
The Taskforce also noted that the green shield will not change to yellow on the ‘BeAware’ application for this age group if they do not receive a booster shot.
 
The Taskforce noted that  updating vaccination protocols are in line with steps taken by the Kingdom of Bahrain  to address the global pandemic, and maintain public health.